Locate your nearest distributor

Text search:

Sartorius closes acquisition of the Biohit liquid handling business

15.12.2011 10:00

  • Significant expansion of the Sartorius product portfolio for laboratories
  • Integration process has begun

Goettingen, December 15, 2011 - Yesterday Sartorius, a leading international process and laboratory technology provider, successfully completed its acquisition of the liquid handling business of the Finnish laboratory supplier Biohit Oyj. The transaction had been announced on October 26, 2011.

With this purchase, Sartorius is pursuing its strategy to expand its product offering for labo-ratory applications. Mechanical and electronic pipettes are among the types of small instru-mentation most frequently used in laboratories. So far, the company has been offering its customers in this segment primarily laboratory balances, laboratory water purification sys-tems, moisture analyzers and consumables for sample preparation. As a result of this acquisi-tion, the Sartorius laboratory business will represent around one third of the Group’s future sales. The larger Sartorius Biotechnology division supplies products and services for the manufacture of biopharmaceuticals.

“The liquid handling business will make an important contribution to the growth strategy of our laboratory unit,” comments Dr. Joachim Kreuzburg, CEO of Sartorius AG. “I am pleased that we have closed this acquisition as fast as planned. Our first priority in the integration process is to rapidly offer our customers the entire range of products and services with the same high quality we’re known for, all from a single source.”

This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.

This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sar-torius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the infor-mation provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

A Profile of Biohit Liquid Handling
The acquisition covers all assets of the liquid handling segment of Biohit Oyj, including its production facilities in Finland and China, as well as its sales subsidiaries in eight countries. This liquid handling segment is one of the global market leaders for mechanical and electronic pipettes, as well as for the associated consumables. The Biohit liquid handling segment, which employs some 400 people, generated net sales of approximately 38 million euros and an EBITDA margin of around 13% in fiscal 2010. Its major customers are research, quality assurance and academic laboratories as well as hospitals. The purchase price was 68 million euros.